Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Oct 31, 2025 | (Q2)Jul 31, 2025 | (Q1)Apr 30, 2025 | (FY)Jan 31, 2025 | (Q4)Jan 31, 2025 | (Q3)Oct 31, 2024 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 47.06%55.97M | 16.49%44.23M | -7.75%36.04M | -11.46%155.82M | 2.68%40.74M | -27.40%38.06M | -18.98%37.97M | 5.46%39.06M | -15.58%176M | -14.89%39.68M |
| Cost of revenue | 26.16%48.97M | 16.29%43.21M | -4.93%32.74M | -13.49%143.24M | -8.16%33.5M | -16.70%38.81M | -20.45%37.16M | -3.81%34.44M | -9.94%165.58M | -11.27%36.48M |
| Gross profit | 1,031.38%7M | 25.81%1.01M | -28.69%3.3M | 20.74%12.59M | 126.11%7.24M | -112.90%-752K | 433.77%806K | 272.98%4.63M | -57.67%10.42M | -41.90%3.2M |
| Operating expense | 31.81%5.32M | -21.49%2.97M | -21.25%2.94M | -2.27%16.72M | 25.03%5.43M | -2.32%4.04M | -24.01%3.78M | -8.58%3.73M | -22.14%17.11M | -58.23%4.34M |
| Selling and administrative expenses | ---- | ---- | ---- | -9.41%13.75M | ---- | ---- | ---- | ---- | -11.54%15.18M | ---- |
| -Selling and marketing expense | ---- | ---- | ---- | -2.39%3.07M | ---- | ---- | ---- | ---- | -11.84%3.14M | ---- |
| -General and administrative expense | ---- | ---- | ---- | -11.25%10.68M | ---- | ---- | ---- | ---- | -11.47%12.04M | ---- |
| Other operating expenses | 31.81%5.32M | -21.49%2.97M | -21.25%2.94M | 53.94%2.97M | 25.03%5.43M | -2.32%4.04M | -24.01%3.78M | -8.58%3.73M | -59.97%1.93M | 164.13%4.34M |
| Operating profit | 135.14%1.68M | 34.31%-1.95M | -59.73%360K | 38.15%-4.13M | 259.63%1.82M | -382.04%-4.79M | 38.35%-2.97M | 131.47%894K | -351.85%-6.68M | 76.68%-1.14M |
| Net non-operating interest income (expenses) | 14.95%-1.32M | -10.82%-1.41M | 0.72%-1.24M | 5.49%-5.25M | 33.54%-1.52M | -2.44%-1.55M | -40.37%-1.28M | -3.07%-1.24M | -17.61%-5.56M | -135.53%-2.29M |
| Non-operating interest income | ---- | ---- | ---- | 96.13%710K | ---- | ---- | ---- | ---- | 63.80%362K | ---- |
| Non-operating interest expense | -14.95%1.32M | 10.82%1.41M | -0.72%1.24M | -1.12%5.74M | -33.54%1.52M | 2.44%1.55M | 40.37%1.28M | 3.07%1.24M | 21.43%5.8M | 122.90%2.29M |
| Total other finance cost | ---- | ---- | ---- | 93.91%223K | ---- | ---- | ---- | ---- | -30.72%115K | ---- |
| Net investment income | 0.00%12K | -20.00%12K | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 1K | 0 | 191.18%31K | 29.07%-61K | 405.56%55K | 0 | -1,271.43%-82K | 50.00%-34K | 59.43%-86K | 88.82%-18K |
| Special income (charges) | 276.68%2.86M | 577.36%759K | ||||||||
| Less:Other special charges | ---- | ---- | ---- | -204.50%-3.58M | ---- | ---- | ---- | ---- | -427.80%-1.18M | ---- |
| Less:Write off | ---- | ---- | ---- | 73.44%725K | ---- | ---- | ---- | ---- | 9.42%418K | ---- |
| Other non-operating income (expenses) | -34.25%428K | -90.01%383K | -3.29%499K | 13.32%1.69M | 850.00%988K | 8.32%651K | 115.10%3.83M | -6.35%516K | -60.20%1.49M | -72.34%104K |
| Income before tax | 113.92%792K | -499.20%-2.98M | -361.36%-345K | 51.43%-4.89M | 140.08%1.34M | -832.30%-5.69M | 87.37%-498K | 103.70%132K | -868.55%-10.07M | 42.21%-3.34M |
| Income tax | 248.00%1.04M | 844.59%551K | -21.36%405K | 183.31%2.05M | 141.96%963K | 1,975.00%300K | -182.22%-74K | 103.56%515K | -80.84%725K | -78.50%398K |
| Net income | 95.79%-252K | -733.73%-3.54M | -95.82%-750K | 35.66%-6.94M | 110.04%375K | -855.36%-5.99M | 89.48%-424K | 89.97%-383K | -336.26%-10.79M | 51.02%-3.74M |
| Net income continuous operations | 95.79%-252K | -733.73%-3.54M | -95.82%-750K | 35.66%-6.94M | 110.04%375K | -855.36%-5.99M | 89.48%-424K | 89.97%-383K | -336.26%-10.79M | 51.02%-3.74M |
| Noncontrolling interests | 40.47%840K | 88.44%375K | 10.29%375K | 156.05%1.1M | 598.46%454K | -29.98%598K | 120.66%199K | 232.81%340K | 279.92%430K | 105.20%65K |
| Net income attributable to the company | 83.42%-1.09M | -527.61%-3.91M | -55.60%-1.13M | 28.32%-8.05M | 98.26%-79K | -10,700.00%-6.59M | 79.70%-623K | 79.70%-723K | -402.15%-11.22M | 28.95%-4.53M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 83.42%-1.09M | -527.61%-3.91M | -55.60%-1.13M | 28.32%-8.05M | 98.26%-79K | -10,700.00%-6.59M | 79.70%-623K | 79.70%-723K | -402.15%-11.22M | 28.95%-4.53M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 83.47%-0.0188 | -530.84%-0.0675 | -55.20%-0.0194 | 28.31%-0.1388 | 98.21%-0.0014 | -10,236.36%-0.1137 | 79.77%-0.0107 | 79.67%-0.0125 | -401.55%-0.1936 | 28.97%-0.0782 |
| Diluted earnings per share | 83.47%-0.0188 | -530.84%-0.0675 | -55.20%-0.0194 | 28.31%-0.1388 | 98.21%-0.0014 | -10,236.36%-0.1137 | 79.77%-0.0107 | 79.67%-0.0125 | -401.55%-0.1936 | 28.97%-0.0782 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.